Valuation: Procyon Corporation

Market Cap 1.55M 1.32M 1.24M 1.13M 2.13M 148M 2.16M 14.65M 5.71M 74.34M 5.81M 5.68M 246M P/E 2023
-25x
P/E 2024 -5.75x
Enterprise Value 1.06M 912K 853K 781K 1.47M 102M 1.49M 10.08M 3.93M 51.17M 4M 3.91M 169M EV / Sales 2023
0.34x
EV / Sales 2024 0.28x
Free-Float
35.53%
Yield 2023 *
-
Yield 2024 -
1 day-10.71%
1 week-10.71%
Current month-10.71%
3 months+24.38%
6 months+32.98%
Current year+106.61%
1 week 0.25
Extreme 0.25
0.25
1 month 0.25
Extreme 0.25
0.28
Current year 0.12
Extreme 0.12
0.28
1 year 0.1
Extreme 0.1
0.28
3 years 0
Extreme 1.0E-6
0.34
5 years 0
Extreme 1.0E-6
0.64
10 years 0
Extreme 1.0E-6
1
Manager TitleAgeSince
Chief Executive Officer 49 08/01/2018
Chief Executive Officer 56 21/09/2005
Director TitleAgeSince
Director/Board Member 49 31/12/2005
Director/Board Member 56 30/11/2006
Chairman 79 31/08/2005
Date Insider Type Main position Quantity % Market Cap.
31/07/24 Other

Director

12,848 0.1585%
31/07/24 Other

Director

7,200 0.0888%
31/07/24 Other

Director

5,600 0.0691%
Change 5-day change 1-year change 3-year change Capi.($)
-10.71%-10.71%+145.10%+13.64% 2.05M
+0.88%+3.84%+77.96%+129.75% 1,109B
+1.07%+3.11%+51.11%+56.67% 644B
+1.20%+5.64%+26.68%+76.48% 463B
+1.02%+3.67%+43.14%+47.27% 371B
+0.85%+2.97%+24.48%+42.54% 301B
+1.26%+4.54%+2.20%+14.84% 256B
+1.88%+5.14%+48.20%+67.80% 234B
+1.59%+0.87%-12.95%-51.91% 205B
+1.87%+5.78%+23.07%+92.57% 178B
Average +0.09%+2.95%+42.90%+48.96% 376.11B
Weighted average by Cap. +1.14%+4.02%+44.79%+72.24%

Financials

2023 2024
Net sales 4.69M 4.01M 3.76M 3.44M 6.45M 448M 6.54M 44.38M 17.31M 225M 17.6M 17.22M 745M 4.98M 4.27M 4M 3.66M 6.86M 477M 6.95M 47.2M 18.41M 240M 18.72M 18.31M 792M
Net income -50.24K -43.04K -40.27K -36.86K -69.18K -4.81M -70.1K -476K -186K -2.41M -189K -185K -7.99M -341K -292K -273K -250K -470K -32.64M -476K -3.23M -1.26M -16.4M -1.28M -1.25M -54.23M
Net Debt -427K -366K -343K -314K -589K -40.9M -596K -4.05M -1.58M -20.55M -1.61M -1.57M -67.96M -482K -413K -386K -354K -664K -46.13M -673K -4.57M -1.78M -23.17M -1.81M -1.77M -76.64M
Logo Procyon Corporation
Procyon Corporation operates through its subsidiary AMERX Health Care Corporation (AMERX). AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. It provides skin and wound care products through its proprietary brands, AMERIGEL Advanced Skin and Wound Care, HELIX3 Bioactive Collagen, and EXTREMIT-EASE compresson Garment. Its AMERIGEL products are made with Oakin, that promote healing in wounds and problematic skin conditions while fighting infection, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its kits and dressings products include AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Thin Hydrocolloid Dressings, and AMERX Wound Care Kits.
Employees
20
Date Price Change Volume
17/08/26 US$0.2500 -10.71% 5,000
  1. Stock Market
  2. Stocks
  3. PCYN Stock